Epigenetics and lung cancer

M. Sanchez-Cespedes (Barcelona, Spain)

Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications

Session: Deadly networks: disease-causing protein and DNA modifications
Session type: Hot topics
Number: 347

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Sanchez-Cespedes (Barcelona, Spain). Epigenetics and lung cancer. Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Epigenetics and lung cancer Source: Annual Congress 2006 - Epigenetics and respiratory disease Year: 2006
Epigenetics in IPF and lung cancer Source: Research Seminar 2015 Year: 2015
Metabolomics in lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
Aerosoltherapy in lung cancer Source: Annual Congress 2008 - Therapy in thoracic oncology Year: 2008
Venothromboembolism in lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 601s Year: 2007
Highlights in lung cancer Source: Eur Respir J 2001; 18: 617-618 Year: 2001
Screening for lung cancer Source: International Congress 2017 – Lung cancer for the pulmonologist Year: 2017
Immunotherapies for lung cancer Source: International Congress 2018 – ME12 Immunotherapies for lung cancer FULLY BOOKED Year: 2018
Epigenetic alterations in the circulating DNA from blood of patients with COPD and lung cancer Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013
Lung cancer Source: Virtual Congress 2020 – Impact in children and in adults with premorbid respiratory disease (acute and long-term) Year: 2020